Inclusion Criteria:  ACS patients hospitalized during the following period: from January 2019 to September 2019 Patients receiving ticagrelor as part of DAPT at hospital discharge. Patient enrolled into the follow-up program of ACS patients  Exclusion Criteria:  Patients participated in other interventional clinical trials